Text and Data Mining valid from 2016-05-27
First Online: 27 May 2016
: M.A.T. has an equity stake in Exerkine Corporation. M.A.T. is the Chief Executive Officer and President, and A. Safdar is the Chief Scientific Officer of Exerkine Corporation. Exerkine has filed patents for the use of exerkines and exersomes to treat metabolic disease, and the use of exosomes to treat genetic disorders.